Clincosm LogoSign in Get a demo

Self Management Programme on the Sustained Attention and Sleep Quality of the Nurses

Sponsor
Uskudar University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05185466
Collaborator
(none)
52
Enrollment
1
Location
2
Arms
4.8
Anticipated Duration (Months)
10.9
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The aim of this study is to examine the effect of the nurse-supported self-management program on the sustained attention and sleep quality of night shift nurses. The self-management program consists of training and incentives for night shift nurses to gain healthy eating habits and improve their sleep health.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Nurse-Supported Self Management Programme
 N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
52 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Other
Official Title:
The Effect of Nurse-Supported Self Management Programme on the Sustained Attention and Sleep Quality of the Nurses Working at Night Shift
Actual Study Start Date :
Oct 13, 2021
Anticipated Primary Completion Date :
Jan 7, 2022
Anticipated Study Completion Date :
Mar 7, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental Group

Experimental Group

Behavioral: Nurse-Supported Self Management Programme
Training and incentives to improve nutrition habits and sleep health.
No Intervention: Control Group

Control Group

Outcome Measures

Primary Outcome Measures

  1. Sustained Attention [First Month]

    Psychomotor Vigilance Test

  2. Sleep Quality [First Month]

    Pittsburgh Sleep Quality Index (PSQI)

  3. Sleepiness [First Month]

    Epworth Sleepiness Scale

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

  • Nurses working in shifts

  • Those between the ages of 18-65

  • Those who agree to participate in the study.

Exclusion Criteria:

  • Pregnant and having suspicion of pregnancy

  • Having vision and hearing problems

  • Having diagnosed sleep disorder

  • Having a chronic disease that will prevent participation in the study

  • Having a diagnosed mental health problem

Contacts and Locations

Locations

Site City State Country Postal Code
1 Istanbul / Turkey Istanbul Turkey

Sponsors and Collaborators

  • Uskudar University

Investigators

  • Principal Investigator: Merve Çolak, MSc, T.C. Üsküdar Üniversitesi

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Merve Çolak, Teaching Assistant, Uskudar University
ClinicalTrials.gov Identifier:
NCT05185466
Other Study ID Numbers:
  • 61351342/Ocak 2021-88
First Posted:
Jan 11, 2022
Last Update Posted:
Jan 19, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 19, 2022